麻风治疗发展史

doi:10.12144/zgmfskin202403225

leprosy,"/> <span style="font-size:12px;">The past and present of leprosy treatment</span>

China Journal of Leprosy and Skin Diseases ›› 2024, Vol. 40 ›› Issue (3): 225-228.doi: 10.12144/zgmfskin202403225

Previous Articles

The past and present of leprosy treatment

MAO Chong, XIONG Junhao

Sichuan Academy of Medical Sciences·Sichuan Provincial People's Hospital, Hospital of The University of Electronic Science and Technology, Chengdu 610072, China

Online:2024-03-15 Published:2024-02-28

Abstract

MAO Chong, XIONG Junhao. The past and present of leprosy treatment[J].China Journal of Leprosy and Skin Diseases, 2024, 40(3): 225-228.

0
/ / Recommend leprosy”. Please open it by linking:http://www.zgmfskin.com/EN/abstract/abstract12255.shtml" name="neirong"> leprosy">

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.zgmfskin.com/EN/10.12144/zgmfskin202403225

http://www.zgmfskin.com/EN/Y2024/V40/I3/225

[1]	WANG Jianwen, CHEN Xuechao, ZHOU Guizhi, CHEN Shengli, LU Xianmei, ZHANG Xueyan, ZHANG Fan, LIU Yongxia. Clinical and histopathological characters of 28 cases of subungual melanoma [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 182-185.
[2]	HAN Jinghong, LIU Hong. Two children with refractory atopic dermatitis successfully treated with Janus kinase inhibitors [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 190-192.
[3]	LU Yu, JIANG Dong, YANG Dengke, HU Siyuan, YUAN Dezheng, ZHOU Xiaomei, QIN Jianping, GE Jinhong, ZHANG Fengrui, LI Wenyao, GUO Yiyu. Adalimumab for the treatment of perifolliculitis capitis abscedens et suffodiens: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 210-211.
[4]	LIU Yan, LIU Mengmeng, LIU Yongxia, LU Xianmei, LIU Guoyan. Generalized fibrous hamartoma in infants: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 212-214.
[5]	XIONG Fei, CAO Jingjiang. Orf: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 214-215.
[6]	JIAO Yuzhu, YANG Qing. Update of treatment of pyoderma gangrenosum [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 216-220.
[7]	ZHANG Ying, NIU Xuping. Update of targeted treatment of pemphigus [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 221-224.
[8]	BI Zhaohua, XIE Kai, LIU Guoyan, CHEN Shengli, GUO Xuan. Mohs microsurgery in treatment of eccrine porocarcinoma [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 113-115.
[9]	QU Peng, DU Donghong, YANG Baoqi. Omalizumab in the treatment of childhood solar urticaria: a case report and literature review [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 116-117.
[10]	ZHANG Ting, CAO Yu. Nodular melanoma misdiagnosed as trichoblastoma: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 118-121.
[11]	JIANG Jiahong, GAO Lina, GU Ankang, ZHANG Jun, GUO Haixia. Eccrine porocarcinoma: three cases report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 121-124.
[12]	HU Mingyu, XU Weiwei, ZHOU Pengpeng, TANG Junting. Erythema elevatum diutinum associated with multiple systemic damage: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 124-126.
[13]	ZHANG Beibei, LIU Ligen, SONG Ningjing. Rare extranodal NK/T cell lymphoma presenting as eosinophilic syndrome: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 127-130.
[14]	QI Miao, CHANG Jiayu, WANG Yimin, LI Yongxi, SHI Tongxin. Erythroderma caused by pityriasis rubra pilaris with anterior mediastinal schwannoma: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 130-133.
[15]	CUI Yinling, ZHENG Chunzhi, YU Yongmei, LIU Hong. Palmoplantar psoriasis resistant to secukinumab successfully treated with tofacitinib: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 134-136.

The past and present of leprosy treatment

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 10